Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy
Immunotherapy based on immune checkpoint inhibitors has evolved into a new pillar of
cancer treatment in clinics, but dealing with treatment resistance (either primary or acquired) …
cancer treatment in clinics, but dealing with treatment resistance (either primary or acquired) …
Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy
T Zhang, Y Jia, Y Yu, B Zhang… - … drug delivery reviews, 2022 - pubmed.ncbi.nlm.nih.gov
Immunotherapy based on immune checkpoint inhibitors has evolved into a new pillar of
cancer treatment in clinics, but dealing with treatment resistance (either primary or acquired) …
cancer treatment in clinics, but dealing with treatment resistance (either primary or acquired) …
Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy.
T Zhang, Y Jia, Y Yu, B Zhang, F Xu… - Advanced Drug Delivery …, 2022 - europepmc.org
Immunotherapy based on immune checkpoint inhibitors has evolved into a new pillar of
cancer treatment in clinics, but dealing with treatment resistance (either primary or acquired) …
cancer treatment in clinics, but dealing with treatment resistance (either primary or acquired) …
[引用][C] Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy
T Zhang, Y Jia, Y Yu, B Zhang, F Xu… - Advanced Drug Delivery …, 2022 - cir.nii.ac.jp
Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …